Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
J Dev Orig Health Dis ; 9(6): 566-572, 2018 12.
Article in English | MEDLINE | ID: mdl-29310731

ABSTRACT

We recently reported augmentation of lipid peroxidation products in the liver of intrauterine growth-restricted (IUGR) piglets fed a high load of Maillard reaction products (MRPs) during suckling period. The underlying mechanisms of MRPs effects remain unknown. Here, we studied the long-term impact of MRPs exposure on liver oxidative status of IUGR juvenile pigs. Livers of 54-day-old pigs suckled with formula containing either a high (HHF, n=8) or a low (LHF: n=8) load of MRPs were analyzed for protein carbonylation levels , activities and messenger RNA (mRNA) expression of glutathione (GSH) and main antioxidant regulators of redox homeostasis [Superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were measured. In addition, mRNA levels of miRNA-21 and miRNA-155 were measured. The liver of HHF group exhibited a high level of lipid peroxidation with significantly increased expression and activity of SOD. Further in liver of HHF group, CAT activity was decreased as compared with LHF group, though with comparable total protein carbonyl contents, GSH contents, and expression of GPx and microRNAs (miRNA-21 and miRNA-155). Our findings suggest that the potential mechanism of MRPs-mediated oxidative stress programming in liver of IUGR piglets may occur via impairment of antioxidant defenses.


Subject(s)
Fetal Growth Retardation/metabolism , Glycation End Products, Advanced/adverse effects , Liver/growth & development , Milk Substitutes/chemistry , Oxidative Stress/drug effects , Animals , Animals, Newborn/physiology , Catalase/genetics , Catalase/metabolism , Female , Gene Expression Regulation, Developmental/drug effects , Gene Expression Regulation, Developmental/genetics , Glutathione Peroxidase/genetics , Glutathione Peroxidase/metabolism , Glycation End Products, Advanced/administration & dosage , Lipid Peroxidation/drug effects , Lipid Peroxidation/genetics , Liver/drug effects , Liver/metabolism , MicroRNAs/metabolism , Milk Substitutes/administration & dosage , Models, Animal , Oxidation-Reduction/drug effects , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Swine , Weaning
3.
J Dev Orig Health Dis ; 7(5): 505-512, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27292028

ABSTRACT

It is now accepted that the way our health evolves with aging is intimately linked to the quality of our early life. The present review highlights the emerging data of Developmental Origins of Health and Disease field on developmental disruption by toxicants and their subsequent effect on type 2 diabetes. We report adverse neonatal effects of several food contaminants during pregnancy and lactation, among them bisphenol A, chlorpyrifos, perfluorinated chemicals on pancreas integrity and functionality in later life. The described alterations, in conjunction with disruption of ß cell mass in early life, can lead to dysregulation of glucose metabolism, insulin synthesis, which facilitates the development of insulin resistance and progression of diabetes in the adult. Despite limited and often inconclusive epidemiologic and experimental data, more recent data clearly show that infants appear to be at increased risk of type 2 diabetes in later life. This may be a result of continued exposure to chemical food contaminants during the critical window of pancreas development. In societies already burdened with increased incidence of non-communicable chronic diseases, there is a clear need for information regarding the potential harmful effects of chemical food contaminants on adult health diseases.

4.
Am J Physiol Endocrinol Metab ; 295(5): E1117-25, 2008 Nov.
Article in English | MEDLINE | ID: mdl-18780769

ABSTRACT

Low birth weight resulting from intrauterine growth retardation (IUGR) is a risk factor for further development of metabolic diseases. The pig appears to reproduce nearly all of the phenotypic pathological consequences of human IUGR and is likely to be more relevant than rodents in studies of neonatal development. In the present work, we characterized the model of low-birth-weight piglets with particular attention to the hypothalamic leptin-sensitive system, and we tested whether postnatal leptin supplementation can reverse the precocious signs of adverse metabolic programming. Our results demonstrated that 1) IUGR piglets present altered postnatal growth and increased adiposity; 2) IUGR piglets exhibit abnormal hypothalamic distribution of leptin receptors that may be linked to further disturbance in food-intake behavior; and 3) postnatal leptin administration can partially reverse the IUGR phenotype by correcting growth rate, body composition, and development of several organs involved in metabolic regulation. We conclude that IUGR may be characterized by altered leptin receptor distribution within the hypothalamic structures involved in metabolic regulation and that leptin supplementation can partially reverse the IUGR phenotype. These results open interesting therapeutic perspectives in physiopathology for the correction of defects observed in IUGR.


Subject(s)
Fetal Growth Retardation/metabolism , Hypothalamus/metabolism , Leptin/pharmacology , Receptors, Leptin/genetics , Sus scrofa/metabolism , Adipocytes, White/cytology , Adipocytes, White/drug effects , Adipocytes, White/metabolism , Adipose Tissue, White/drug effects , Adipose Tissue, White/growth & development , Adipose Tissue, White/metabolism , Animals , Animals, Newborn , Birth Weight/drug effects , Blood Glucose/metabolism , Body Composition/drug effects , Body Composition/physiology , Body Size/drug effects , Body Weight/drug effects , Female , Fetal Growth Retardation/blood , Fetal Growth Retardation/drug therapy , Gene Expression/drug effects , In Situ Hybridization , Leptin/blood , Leptin/therapeutic use , Sus scrofa/growth & development , Triglycerides/blood , Weight Gain/drug effects
5.
Int J Obes (Lond) ; 32(7): 1153-60, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18379577

ABSTRACT

OBJECTIVE: Using a recombinant rat leptin antagonist, we investigated the effects of early postnatal leptin disruption on long-term leptin sensitivity and metabolic phenotype. DESIGN: Three groups of 10 newborn female Wistar rats were injected subcutaneously with either saline (control) or leptin antagonist (at 2.5 or 7.5 microg g(-1) day(-1)) from postnatal day 2 to day 13. RESULTS: At weaning (day 28), antagonist-treated rats presented similar body weight (BW) compared to control animals. At 3 months of age, there was no significant change in BW, food intake and leptin or insulin levels between groups. Only a disturbed relationship between circulating insulin and glucose levels was observed in antagonist-treated animals. At 4 months of age, treated animals developed a leptin resistance appreciated by the lack of response to a 7-days leptin treatment (1 mg kg(-1) day(-1)) in term of decrease in food intake and BW. At 8 months of age, following 3 months of high-energy diet, rlepm7.5 animals presented higher BW gain associated with increased body fatness and striking hyperleptinaemia as compared to control animals. CONCLUSION: The blockage of leptin action during the critical period of early life in rodents has long-term consequences by altering the capacity to respond to leptin during adulthood, thus predisposing the animals to obesity. These findings clearly demonstrate the physiological importance of the postnatal leptin surge for the optimal onset of the metabolic regulation, at least in rodents, and its implication in the prevention of unfavourable developmental programming.


Subject(s)
Leptin/antagonists & inhibitors , Obesity/metabolism , Animals , Animals, Newborn , Body Weight , Disease Susceptibility , Eating , Female , Insulin/blood , Leptin/blood , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage , Time , Weaning
6.
Gynecol Obstet Fertil ; 31(9): 774-7, 2003 Sep.
Article in French | MEDLINE | ID: mdl-14499726

ABSTRACT

Recent studies from WHO indicated that a large proportion of human contraceptive needs cannot be covered by the already existing means for different reasons (medical, economical, political, and cultural). Therefore, development of new effective methods targeting birth control methods affordable by under-privileged populations turns out to be necessary. Over the last 20 years, a large number of strategies have been used for contraceptive vaccines and thus multiple antigens have been identified as potential targets for immunocontraception. Nowadays, the most acute researches are based on suppression of the secretion and the activity of gonadotropic hormones (GnRH, LH/hCG, FSH) or the targeting of antibodies specific to sperm surface (RSA-1, SP10, SP17, TCLe-1, PH-20) and oocyte antigens (ZP1, ZP2, ZP3). We developed a contraceptive vaccine against FSH receptor. Adult male monkeys (Macaca radiata) were immunized with filamentous phages displaying at their surface N-terminal peptides of the FSH receptor. Long term male contraception has been achieved without any alteration of circulating testosterone levels, sexual behaviour or of any other discernable metabolic changes. Interruption of vaccination resulted in full recovery of sperm production and male fertility. Contraceptive vaccines are aimed to block an essential step in the reproductive process. From this point of view, efforts have to be focused on the challenge to raise is to ally our knowledge on reproductive physiology and protein biochemistry for a better understanding of the target antigen's function.


Subject(s)
Contraception, Immunologic , Animals , Antigens/immunology , Chorionic Gonadotropin/immunology , Contraception, Immunologic/methods , Female , Gonadotropin-Releasing Hormone/immunology , Humans , Immunization , Male , Oocytes/immunology , Receptors, FSH , Spermatozoa/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...